Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC

  1. Baraibar, I.
  2. Mezquita, L.
  3. Gil-Bazo, I.
  4. Planchard, D.
Revue:
Critical Reviews in Oncology/Hematology

ISSN: 1879-0461 1040-8428

Année de publication: 2020

Volumen: 148

Type: Révision

DOI: 10.1016/J.CRITREVONC.2020.102906 GOOGLE SCHOLAR

Objectifs de Développement Durable